Genetic Evidence Supporting Autoimmunity In Ms

Epidemiologic data strongly support a genetic predisposition to MS. Other putative autoimmune diseases such as SLE and rheumatoid arthritis are well documented to occur at a higher frequency within families of affected patients than in the general population (41). Twenty percent of patients with MS report a positive family history for MS (42,43). Approximately 30% of monozygotic twins are concordant when one of the twins has MS, while among other siblings the risk is 2% to 5%, and among half-siblings the risk is 1.1% to 1.4% (44). Among adopted siblings and the general U.S. and Canadian populations, the risk is 0.1% (45,46). The familial predisposition to MS has prompted investigations into immune-response genes to explain this enhanced susceptibility.

MHC-II molecules are expressed on the surface of antigen-presenting cells and present processed antigen to CD4+ T-cells (47). The CD4+ T-cell, in turn, is the primary mediator of the animal model for MS, EAE (48), and is strongly implicated in MS. A number of purported autoimmune diseases including rheumatoid arthritis (49), type 1 diabetes mellitus (50), and MS (51) are associated with specific MHC-II haplotypes. This suggests immune mechanisms in their pathophysiology. The MHC II DR2 (HLA DRB1*1501 and DRB1*1503) haplotype has been found to convey susceptibility to MS (51,52). In addition, a "dose effect" of HLA-DR2 haplotypes on both susceptibility and progression of MS has been documented. Patients with two copies of HLA-DR2 have an increased risk of developing MS and of having a more severe course compared with heterozygotes (53). Different HLA II genes appear to influence disease susceptibility in people of non-European descent (54).

Investigations of other immune system-related genes have yielded data in support of an environmental effect superimposed on the genetic predisposition for the immune dysfunction. Utz et al. examined T-cell receptor (TCR) gene usage in T-cells reactive with myelin basic protein (MBP) and tetanus toxoid from concordant and discordant monozygotic twins. They found that MS-affected twins' T-cells selected Va8 TCR after stimulation with MBP, whereas nonaffected discordant twins selected different TCRs (55). These and earlier studies (56) implicate the T-cell as a contributor to MS pathogenesis. In a follow-up study of five pairs of monozygotic twins (two discordant sets, two concordant sets, and one healthy set), Utz et al. (57) confirmed the over expression of Va8 in MBP-specific cells from MS patients, and examined the complementarity-determining region 3 (CDR3) of Va8-positive TCRs. The latter studies demonstrated a profound heterogeneity of CDR3 usage, which correlated with disease severity. The extensive heterogeneity was restricted to MS-affected subjects, and was limited to T-cells specific for MBP and not seen in cells specific for tetanus toxoid. The data were interpreted as being suggestive of a role for MBP-reactive T-cells in MS pathogenesis.

The theory of autoimmune disease postulates that loss of T-cell tolerance to self-antigens underlies the development of the autoimmune reaction. Dysfunction of the CTLA-4 receptor is one possible mediator of this lack of self-tolerance. Both CD28 and CTLA-4 are T-cell receptors for the costimulatory B7 molecules expressed on antigen presenting cells (APC). Most T-cells bear the CD28 receptor, which upon ligation contributes to T-cell activation with ensuing secretion of the pro-inflammatory cytokine IL-2 (58). T-cell activation induces expression of CTLA-4 (59). Ligation of CTLA-4 by B7 molecules, on the other hand, causes T-cell inactivation. Oliveira et al. (60) sought to determine whether the CTLA-4 receptor behaved differently in MS patients compared to controls. Blocking the CTLA-4:B7 interaction, following stimulation with MBP, led to increased proliferation and cytokine production by T-cells from healthy controls compared with MS patients. Thus, MS patient cells may have impaired sensitivity to the regulatory effects of CTLA-4. Polymorphisms of the CTLA-4 exon 1 have been associated with rheumatoid arthritis, Grave's disease, type 1 diabetes mellitus, and MS (61,62). Presence of the A allele of the CTLA-4 gene may convey a worse prognosis with regards to MS progression (63).

Arthritis Relief and Prevention

Arthritis Relief and Prevention

This report may be oh so welcome especially if theres no doctor in the house Take Charge of Your Arthritis Now in less than 5-Minutes the time it takes to make an appointment with your healthcare provider Could you use some help understanding arthritis Maybe a little gentle, bedside manner in your battle for joint pain relief would be great Well, even if you are not sure if arthritis is the issue with you or your friend or loved one.

Get My Free Ebook

Post a comment